Abbott India Limited

BSE:500488 Stock Report

Market Cap: ₹608.5b

Abbott India Past Earnings Performance

Past criteria checks 5/6

Abbott India has been growing earnings at an average annual rate of 17.2%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 9.2% per year. Abbott India's return on equity is 36.5%, and it has net margins of 21.2%.

Key information

17.2%

Earnings growth rate

17.2%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate9.2%
Return on equity36.5%
Net Margin21.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Abbott India makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BSE:500488 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2460,66112,8477,0730
30 Jun 2459,27512,3907,0260
31 Mar 2458,48912,0126,9100
31 Dec 2357,53411,4566,7990
30 Sep 2356,38410,8146,7600
30 Jun 2355,23610,3406,8280
31 Mar 2353,4879,4946,8550
31 Dec 2252,6549,2947,2850
30 Sep 2251,6328,8187,3480
30 Jun 2250,0588,0867,4220
31 Mar 2249,1337,9877,3560
31 Dec 2147,5987,3986,8520
30 Sep 2146,3087,1776,6320
30 Jun 2144,6367,0616,2960
31 Mar 2143,1006,9076,1260
31 Dec 2041,7576,4926,3450
30 Sep 2041,5866,5876,3390
30 Jun 2041,5856,5634,8440
31 Mar 2040,9315,9296,2270
31 Dec 1940,3835,9526,3570
30 Sep 1939,0775,2556,2310
30 Jun 1938,3264,8496,0760
31 Mar 1936,7864,5036,0220
31 Dec 1835,6064,3725,7270
30 Sep 1834,9414,3555,5750
30 Jun 1834,4604,3545,5060
31 Mar 1832,9854,0125,3250
31 Dec 1732,2423,4324,7600
30 Sep 1730,8933,1344,7270
30 Jun 1728,7942,5094,6130
31 Mar 1729,0262,7664,5170
31 Dec 1628,9592,9804,4020
30 Sep 1628,0972,8024,4030
30 Jun 1627,2932,6634,4030
31 Mar 1626,1452,5534,4440
31 Dec 1525,3802,5046,1940
30 Sep 1524,5042,4456,1090
30 Jun 1523,9502,4666,0160
31 Mar 1522,8932,2904,0020
31 Dec 1422,0082,1765,9430
30 Sep 1421,1032,0655,7060
30 Jun 1419,7761,8805,5580
31 Mar 1418,6941,6685,5410
31 Dec 1317,5271,6012,3130

Quality Earnings: 500488 has high quality earnings.

Growing Profit Margin: 500488's current net profit margins (21.2%) are higher than last year (19.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 500488's earnings have grown by 17.2% per year over the past 5 years.

Accelerating Growth: 500488's earnings growth over the past year (18.8%) exceeds its 5-year average (17.2% per year).

Earnings vs Industry: 500488 earnings growth over the past year (18.8%) did not outperform the Pharmaceuticals industry 20%.

Return on Equity

High ROE: 500488's Return on Equity (36.5%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 18:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abbott India Limited is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Abdulkader PuranwalaAnand Rathi Shares and Stock Brokers Limited
Shareen BatatawalaAngel Broking Private Limited
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.